Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
667 Predictive value of circulating tumor DNA in patients with advanced HPV16-positive cervical cancer treated with VB10.16 in combination with atezolizumab
Compose a Response to This Article
Other responses
No responses have been published for this article.